Heterogeneity of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer and potential effects on therapy in the CAPRI GOIM trial.

Guido Rindi

Risultato della ricerca: Contributo in rivista › Articolo in rivista

89 Citazioni (Scopus)

Fingerprint

Entra nei temi di ricerca di 'Heterogeneity of KRAS, NRAS, BRAF and PIK3CA mutations in metastatic colorectal cancer and potential effects on therapy in the CAPRI GOIM trial.'. Insieme formano una fingerprint unica.

Biochemistry, Genetics and Molecular Biology